- Date: Jul 28, 2025
- Category:
The dermatology sector is witnessing rapid innovations, driving the dermatology market to a projected valuation of USD 3,140 million by 2032. This growth presents a diverse range of opportunities for contract research organizations (CROs), healthcare businesses, technology providers, and distributors to engage with dermatologists and increase their business profits. Precisely why, in this blog, we will profile top dermatology companies, including their C-suite leadership, headquarters, and most importantly, their financial situations. This in-depth analysis will provide a deeper understanding of the leading dermatology companies and their financial health, enabling investors to make informed decisions.
Top 9 Leading Dermatology Companies in Pharma and Biotech (USA & Global)
The primary objective of this blog is to introduce the key players who have contributed to the advancement of dermatology. Most of the organizations mentioned below are not specifically dermatology companies, except for a few. They are esteemed biotechnology, pharmaceutical, or bio-medical companies that provide products and services in the field of dermatology.
In recent times, the dermatology market has seen the emergence of niche companies, such as Skin Pharma, Skin Analytics, and Dermasensor, among others. These companies are making significant contributions to the advancement of dermatology, underscoring the dynamic and evolving nature of the industry.
Now, let’s move to exploring the key contributor in the dermatology area of expertise!
1. AbbVie Inc.
AbbVie is a research-based biopharmaceutical company committed to developing medicines for complex health issues. Its primary focus is on developing and commercializing medicines for a wide range of treatments. Among them, AbbVie is dedicated to developing impactful therapies for dermatological conditions. They are known for regularly presenting new data at major dermatology conferences. AbbVie’s contribution to the dermatology sector spans medicine development, research, education, and advocacy. This comprehensive involvement not only positions AbbVie as a leader in clinical practice but also underscores its commitment to healthcare inclusivity, contributing to a more equitable healthcare system in the dermatology sector.
- CEO: Richard A. Gonzalez
- Best Known Dermatology Products: RINVOQ (upadacitinib), SKYRIZI (risankizumab) for psoriasis and atopic dermatitis
- Revenue: $57.367 Billion
- Headquarters: North Chicago, Illinois, USA
2. Pfizer Inc.
Pfizer is a leading American multi-national bio-technology and pharmaceutical company. Founded in 1849, it is one of the oldest biomedical companies in the world. It is considered one of the top contributors in the dermatology industry. As it is driven by its unwavering commitment to advancing skin care conditions through clinical research and innovative therapies.
- CEO: Albert Bourla
- Best Known Dermatology Product: Pfizer’s dermatology portfolio includes a wide range of products, such as treatments for atopic dermatitis, melanoma, psoriasis, and acne, among others.
- Revenue: $63.6 Billion
- Headquarters: New York, USA
3. Jhonson & Jhonson
Johnson & Johnson is one of the most notable global healthcare companies, founded in 1886 by three brothers. Their initial product line of ready-to-use, sterile surgical dressings not only gained popularity but also set a standard for patient safety. This continued commitment still remains at the core of the company’s mission.
Johnson & Johnson’s standing in the dermatology industry is a result of their unwavering commitment to scientific innovation and substantial investment in dermatology research and product development. This dedication, coupled with extensive consumer research, has cemented their position in the industry.
- CEO: Joaquin Duato
- Best Known Dermatology Product: Neutrogena (Consumer), Aveeno, Stelara ( biologic for psoriasis)
- Revenue: $89.3 Billion
- Headquarters: New Brunswick, New Jersey, USA
4. Galderma S.A
Galderma is one of the largest dermatology companies. They are present in 90 countries, with a workforce of over 6,000 employees. It was initially founded in a venture with L’Oréal and Nestlé. However, it has since become fully independent, a testament to its strength and autonomy, and completed a full IPO in 2024. Galderma’s main objective is to deliver science-based skin health solutions.
- CEO: Flemming Ørnskov
- Best Known Dermatology Products: Cetaphil, Differin, Sculptra, Soolantra
- Revenue: $4.4 Billion
- Headquarters: Lausanne, Switzerland
5. Sun Pharmaceutical Industries Ltd.
Sun Pharma is a prestigious multinational company situated in Mumbai. It is the fourth-largest specialty pharmaceutical company globally, with a workforce of more than 41,000 employees. It is also considered one of the top dermatology pharmaceutical companies for generic dermatology medicines, mainly in the US. It is ranked second by prescription in the dermatology sector. Their products addressed a wide range of skin care conditions, including fungal infections, psoriasis, alopecia areata, acne, and actinic keratosis.
- CEO: Dilip Shanghvi
- Best Known Dermatology Product: ILUMYA (tildrakizumab-asmn) for psoriasis
- Revenue: $6.2 Billion
- Headquarters: Mumbai, India
6. LEO Pharma
LEO Pharma, a renowned Danish pharmaceutical company specializing in dermatology, is primarily owned by the LEO Foundation. The company serves over 130 countries with a workforce of 4,000 employees. The company has established itself as the global leader in medical dermatology, dedicating decades of research to treating advanced skin care conditions.
- CEO: Catherine Mazzacco
- Best Known Dermatology Products: Enstilar, Protopic for the treatment of acne, atopic eczema, psoriasis.
- Revenue: $1.6 Billion
- Headquarters: Ballerup, Denmark
7. Amgen Inc.
Amgen, a multinational biopharmaceutical company, was originally known as Applied Molecular Genetics. It’s one of the world’s premier biotechnology companies, known for our innovative approach that combines the power of biology, human genetics, and technology to deliver solutions for serious illness. Operating in more than 100 countries, they are at the forefront of the industry. They have also made a lasting impact in the dermatology sector, advancing treatment options and supporting research and innovation for skin-related diseases.
- CEO: Robert A. Bradway
- Best Known Dermatology Products: Brodalumab (Moderate-to-severe plaque psoriasis)
- Revenue: $34.1 Billion
- Headquarters: Thousand Oaks, California, USA
8. DermBiont, Inc
DermBiont is a clinical-stage biotechnology company pioneering precision dermatology. Their mission as one of the established dermatology biotech companies is to lead the global development of targeted topical therapeutics that address the root causes of dermatological disorders, rather than just their symptoms.
- CEO: Peter DiBattista
- Best Known Dermatology Product: Skin Microbiome Therapeutics
- Revenue:$5 Million
- Headquarters: Boston, Massachusetts, USA
9. GSK plc
GSK, a British multinational biotech and pharmaceutical company, is renowned for its vaccines, consumer medicine, and specialty health products. As one of the world’s largest pharmaceutical companies, GSK has a long legacy of innovation and a diverse product range. The GSK dermatology sector plays a crucial role in the healthcare industry, particularly in the development of treatments for immunological and inflammatory conditions. This significant contribution further underscores GSK’s position as a key player in the pharmaceutical industry.
CEO: Emma Walmsley
Best Known Dermatology Product: Stiefel (clindoxyl, stieprox, stieva-a)
Revenue: $42.1 Billion
Headquarters: London, UK
Conclusion:
The dermatology industry holds a significant position in healthcare innovation, as robust research pipelines constantly fuel it. At the same time, there is an increasing demand from patients for effective treatment. All of the organizations mentioned above play a pivotal role in driving scientific advancements in the dermatology industry. Lastly, it is crucial to note that as the market expands exponentially, collaboration with top dermatology companies will be essential to sustain this continued growth and improve patient outcomes globally.
